Patient clips sensors onto shoes, puts headphones over ears, and starts a session
Our technology platform
MedRhythms’ platform is a software platform that allows MedRhythms to develop and iteratively refine neurotherapeutics for a range of neurologic conditions. The platform combines sensors that capture real-time gait data with a personalized rhythmic stimulus delivered as music through proprietary algorithms.
This emulates Rhythmic Auditory Stimulation, an evidence-based therapeutic practice that enables auditory-motor entrainment, the synchronization of the auditory and motor regions of the brain, to produce meaningful therapeutic benefits.
By standardizing components associated with application development, data capture, processing, storage, and rhythmic stimulus delivery, our platform provides the perfect foundation for new product discovery, design, testing, and evolution as scientific evidence and experience advance. The design of the platform is informed by over 30 years of academic research, current clinical best practices, and over 30,000 hours of real-world direct patient care.
- Thaut, M., & Abiru, M. (2010). Rhythmic Auditory Stimulation in Rehabilitation of Movement Disorders: A Review Of Current Research. Music Perception, 27(4), 263-269. doi: https://doi.org/10.1525/mp.2010.27.4.263
Click the arrows below to see an example of an end user configuration.
Sensors collect baseline gait data
Our patented algorithms continuously receive real-time gait data from sensors to curate, augment, and individualize clinical interventions for each patient in real-time based on that user’s data.
Patient listens to the music and walks to the beat.
The algorithms constantly assess the user’s entrainment ability and quality of walking, and provide auditory stimuli to progress them toward an objective clinical goal.
Previous
Next
Our Pipeline
MedRhythms has a robust pipeline of novel, next-generation digital therapeutics in active development. We aim to bring these solutions to a wide range of patients suffering from neurologic impairments that can be improved through auditory-motor entrainment. Additionally, MedRhythms has a number of research initiatives outside of the pipeline below. Contact us at hello@medrhythms.com for more information.
Research
Design & POC
Feasibility
Pivotal Trial
Regulatory
MR-001
Chronic Stroke
Stage: Pivotal Trial
MR-004
Multiple Sclerosis
Stage: Feasibility
MR-005
Parkinson's Disease
Stage: Feasibility
MR-010
Post-Acute Stroke
Stage: Feasibility
MR-012
Functional Neurological Disorder
Stage: Feasibility
MR-009
Aging in Place
Stage: Design & POC
MR-C-001
Cognition
Stage: Design & POC
Clinical Trials
MedRhythms is committed to studying our pipeline products in clinical trials with top institutions, including Cleveland Clinic and Massachusetts General Hospital. Read our press releases about trials we have launched below to learn more.
MR-004 Multiple Sclerosis
May 18, 2021
MR-010 Post-Acute Stroke
April 28, 2021
MR-005 Parkinson’s Disease
April 13, 2021
MR-004 Multiple Sclerosis | MR-005 Parkinson’s Disease
January 14, 2020
MR-001 Chronic Stroke
October 28, 2019